Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · September 16, 2024

Utility of Intravitreal Anti-VEGF Treatment in Patients With Neovascular AMD and Poor Visual Acuity

Retina (Philadelphia, Pa.)

 

Additional Info

Retina (Philadelphia, Pa.)
INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POOR VISUAL ACUITY
Retina (Philadelphia, Pa.) 2024 Sep 01;44(9)1486-1494, JS Song, MS Kim, K Joo, SJ Park, SJ Woo, KH Park

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading